Concomitant hepatocellular carcinoma recurrence and mantle cell lymphoma

Hepatobiliary Pancreat Dis Int. 2024 Aug;23(4):434-437. doi: 10.1016/j.hbpd.2022.06.005. Epub 2022 Jun 16.

Authors

Liang Xue¹, Da-Long Wan¹, Chen Hu¹, Qing-Hong Ke¹, Jie Zhou¹, Yan Shen²

Affiliations

¹ Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
² Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Electronic address: shenyan@zju.edu.cn.

PMID: 35752598
DOI: 10.1016/j.hbpd.2022.06.005

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Hepatocellular* / pathology
Carcinoma, Hepatocellular* / therapy
Hepatectomy
Humans
Liver Neoplasms* / pathology
Liver Neoplasms* / therapy
Lymphoma, Mantle-Cell* / complications
Lymphoma, Mantle-Cell* / pathology
Lymphoma, Mantle-Cell* / therapy
Neoplasm Recurrence, Local*
Treatment Outcome